文献速递特殊人群用药治疗药物监测与药物基因组学

药物基因组学多样性的优势与挑战:少数群体能否推动临床实施?

The Advantages and Challenges of Diversity in Pharmacogenomics: Can Minority Populations Bring Us Closer to Implementation?
PubMed 文献 · Clin Pharmacol Ther · 2019-01-01

本文综述美国少数群体在疾病患病率、死亡率和药物反应上的健康差异,指出遗传变异可解释部分差异。药物基因组学旨在明确遗传变异对药物反应的影响以优化治疗与开发,但全基因组关联研究多在欧亚裔人群开展,导致精准医学健康差异扩大。文章讨论少数群体药物基因组学的优势与混杂因素、药理学通路中遗传变异的作用及群体特异性发现。

要点

  • 多数药物基因组学GWAS以欧亚裔为主,少数群体数据不足加剧精准医学差异。
  • 遗传变异可部分解释少数群体药物反应差异,但差异为多因素所致。
  • 少数群体复杂基因组可能为药物基因组学研究带来真实优势。

核心结论

  • 少数群体在药物基因组学研究中代表性不足,导致精准医学健康差异扩大。
  • 增加少数群体参与可能为药物基因组学带来真实优势并推动临床实施。

研究设计与样本

  • 综述,概述少数群体药物基因组学的优势与混杂因素、药理学通路遗传变异作用及群体特异性发现。

主要发现

  • 美国少数群体存在疾病患病率、死亡率和药物反应差异,这些差异为多因素且遗传变异解释部分变异。
  • 多数药物基因组学GWAS主要在欧亚裔参与者中开展,造成精准医学健康差异扩大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Health disparities exist among minorities in the United States, with differences seen in disease prevalence, mortality, and responses to medications. These differences are multifactorial with genetic variation explaining a portion of this variability. Pharmacogenomics aims to find the effect of genetic variations on drug response, with the goal of optimizing drug therapy and development. Although genome-wide association studies have been useful in unbiasedly surveying the genome for genetic drivers of clinically relevant phenotypes, most of these studies have been conducted in mainly participants of European and Asian descent, contributing to a growing health disparity in precision medicine. Diversity is important to pharmacogenomic studies, and there may be real advantages to the use of these complex genomes in pharmacogenomics. In this review we will outline some of the advantages and confounders of pharmacogenomics in minorities, describe the role of genetic variation in pharmacologic pathways, and highlight a number of population-specific findings.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Zhang H, De T, Zhong Y, et al. The Advantages and Challenges of Diversity in Pharmacogenomics: Can Minority Populations Bring Us Closer to Implementation? Clin Pharmacol Ther. 2019. PMID: 31038731. doi:10.1002/cpt.1491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。